PrFOSAMAX®
(alendronate sodium tablets)
(alendronate sodium oral solution)
Original Notice of Compliance (NoC)
December 18, 1995
Therapeutic / Pharmacological Classification
Bone Metabolism Regulator
Product Monograph / Prescribing Information / Product Information
 |
Date of Revision: October 8, 2009 (09,11-a_131996) File name: FOSAMAX-0911-a_131996_E.pdf File size: 505 KB |
CONSUMER INFORMATION - 5 or 10 mg alendronate daily dosage
|
Date of Revision: October 8, 2009 (09,11-a_131996) File name: FOSAMAX-0911-a_131996_5-10mg_daily_CI_E.pdf File size: 183 KB |
CONSUMER INFORMATION - 40 mg alendronate daily dosage
|
Date of Revision: October 8, 2009 (09,11-a_131996) File name: FOSAMAX-0911-a_131996_40mg_Paget_CI_E.pdf File size: 180 KB |
CONSUMER INFORMATION - 70 mg alendronate once weekly dosage
|
Date of Revision: October 8, 2009 (09,11-a_131996) File name: FOSAMAX-0911-a_131996_70mg_once_weekly_CI_E.pdf File size: 187 KB |
This file is presented in PDF format. This software is available at no charge through the Adobe Web site. Get Adobe Reader
